Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Air Pollution Linked to Respiratory and Cardiovascular Deaths

By HospiMedica International staff writers
Posted on 21 Feb 2017
A new study confirms that as exposure to urban fine particulate air pollution increases, so does deaths from cardiovascular and respiratory diseases.

Researchers at Fudan University, the Chinese Center for Disease Control and Prevention, Emory University, and other institutions conducted an epidemiological study in 272 Chinese cities between 2013 and 2015 in order to evaluate short-term associations between fine particulate (PM2.5) and daily cause-specific mortality. More...
City-specific effects of PM2.5, exposure-response relationship curves, and potential effect modifiers were also evaluated.

The results showed that the average of annual-mean PM2.5 concentrations in each city was 56 µg/m3, well above the World Health Organization (WHO) air quality guidelines of 10 µg/m3; each additional 10 µg/m3 increase in daily PM2.5 concentrations was associated with increments of 0.22% in mortality from total non-accidental causes, 0.27% from cardiovascular diseases, 0.39% from hypertension, 0.30% from coronary heart disease (CAD), 0.23% from stroke, 0.29% from respiratory diseases, and 0.38% from chronic obstructive pulmonary disease (COPD).

Other findings were that mortality was significantly higher among people age 75 and older, and among those with lower levels of education. The study suggests a weaker association between PM2.5 and mortality than studies conducted in Europe and North America, which could indicate that particulate pollution contents in China may be less toxic than those in other countries, possibly because crustal dust from arid lands and construction make up more of PM2.5 in China. The study was published on February 9, 2017, in the American Journal of Respiratory and Critical Care Medicine.

“Our findings may be helpful to formulate public health policies and ambient air quality standards in developing countries to reduce the disease burden associated with PM2.5 air pollution,” said study co-author professor of public health Haidong Kan, MD, of Fudan University. “Further massive investigations, especially looking at the long-term effect studies, are needed to confirm our results and to identify the most toxic components of PM2.5 in China.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.